Skip to Content

5 Results Found

  • Article
  • Open Access
10 Citations
4,169 Views
20 Pages

Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients

  • Tugce Senturk Kirmizitas,
  • Caroline van den Berg,
  • Ruben Boers,
  • Jean Helmijr and ,
  • Stavros Makrodimitris,
  • Hamit Harun Dag,
  • Marijn Kerkhofs,
  • Corine Beaufort,
  • Jaco Kraan and
  • Ingrid Boere
  • + 15 authors+ 10 authors

7 June 2024

Background: Patients with advanced-stage epithelial ovarian cancer (EOC) receive treatment with a poly-ADP ribose-polymerase (PARP) inhibitor (PARPi) as maintenance therapy after surgery and chemotherapy. Unfortunately, many patients experience disea...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
10 Citations
3,054 Views
11 Pages

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting

  • Manouk K. Bos,
  • Sarah R. Verhoeff,
  • Sjoukje F. Oosting,
  • Willemien C. Menke-van der Houven van Oordt and ,
  • Ruben G. Boers,
  • Joachim B. Boers,
  • Joost Gribnau,
  • John W. M. Martens,
  • Stefan Sleijfer and
  • Saskia M. Wilting
  • + 6 authors+ 1 author

21 February 2023

According to the current guidelines, watchful waiting (WW) is a feasible option for patients with good or intermediate prognosis renal-cell carcinoma (RCC). However, some patients rapidly progress during WW, requiring the initiation of treatment. Her...

(This article belongs to the Special Issue Cancer Epigenetic Biomarkers)
  • Article
  • Open Access
17 Citations
3,085 Views
13 Pages

Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma

  • Siyu Fu,
  • Teoman Deger,
  • Ruben G. Boers,
  • Joachim B. Boers and ,
  • Michael Doukas,
  • Joost Gribnau,
  • Saskia M. Wilting,
  • José D. Debes and
  • Andre Boonstra
  • + 4 authors+ 0 author

28 September 2023

Aberrant DNA methylation changes have been reported to be associated with carcinogenesis in cirrhotic HCC, but DNA methylation patterns for these non-cirrhotic HCC cases were not examined. Therefore, we sought to investigate DNA methylation changes o...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
6 Citations
2,691 Views
13 Pages

Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?

  • Ellis L. Eikenboom,
  • Saskia M. Wilting,
  • Teoman Deger,
  • Malgorzata I. Srebniak and ,
  • Monique Van Veghel-Plandsoen,
  • Ruben G. Boers,
  • Joachim B. Boers,
  • Wilfred F. J. van IJcken,
  • Joost H. Gribnau and
  • Anja Wagner
  • + 9 authors+ 4 authors

17 September 2023

Colorectal cancer (CRC) colonoscopic surveillance is effective but burdensome. Circulating tumor DNA (ctDNA) analysis has emerged as a promising, minimally invasive tool for disease detection and management. Here, we assessed which ctDNA assay might...

(This article belongs to the Special Issue Current and Emerging Utility of Liquid Biopsy in Cancers. More than Surrogate Biomarkers)
  • Review
  • Open Access
109 Citations
17,918 Views
17 Pages

Assessing the Costs and Cost-Effectiveness of Genomic Sequencing

  • Kurt D. Christensen,
  • Dmitry Dukhovny,
  • Uwe Siebert and
  • Robert C. Green

10 December 2015

Despite dramatic drops in DNA sequencing costs, concerns are great that the integration of genomic sequencing into clinical settings will drastically increase health care expenditures. This commentary presents an overview of what is known about the c...

(This article belongs to the Special Issue Implementing Personalized Medicine in a Large Health Care System)